A
ATAI Life Sciences NV
ATAI
1.42000
USD
-0.14
(-8.97%)
مغلق
حجم التداول
15,818
الربح لكل سهم
0
العائد الربحي
0
P/E
-3
حجم السوق
182,061,866
العنوان: ATAI Life Sciences NV
القطاع: Healthcare
الصناعة: Biotechnology
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.